img

Global Tysabri (natalizumab) Drug Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tysabri (natalizumab) Drug Market Insights, Forecast to 2034

Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this condition.
Global Tysabri (natalizumab) Drug market is expected to reach to US$ 1929 million in 2024, with a positive growth of %, compared with US$ 2030.9 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Tysabri (natalizumab) Drug industry is evaluated to reach US$ 1463.4 million in 2029. The CAGR will be -4.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Tysabri (natalizumab) Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Tysabri (natalizumab) Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biogen
Novartis
Segment by Type
Multiple Sclerosis
Crohn's Disease

Segment by Application


Hospital
Drugs Stores

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Tysabri (natalizumab) Drug plant distribution, commercial date of Tysabri (natalizumab) Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Tysabri (natalizumab) Drug introduction, etc. Tysabri (natalizumab) Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Tysabri (natalizumab) Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Tysabri (natalizumab) Drug Product Introduction
1.2 Market by Type
1.2.1 Global Tysabri (natalizumab) Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Multiple Sclerosis
1.2.3 Crohn's Disease
1.3 Market by Application
1.3.1 Global Tysabri (natalizumab) Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tysabri (natalizumab) Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Tysabri (natalizumab) Drug Revenue by Region
2.2.1 Global Tysabri (natalizumab) Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Tysabri (natalizumab) Drug Revenue by Region (2018-2024)
2.2.3 Global Tysabri (natalizumab) Drug Revenue by Region (2024-2029)
2.2.4 Global Tysabri (natalizumab) Drug Revenue Market Share by Region (2018-2029)
2.3 Global Tysabri (natalizumab) Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Tysabri (natalizumab) Drug Sales by Region
2.4.1 Global Tysabri (natalizumab) Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Tysabri (natalizumab) Drug Sales by Region (2018-2024)
2.4.3 Global Tysabri (natalizumab) Drug Sales by Region (2024-2029)
2.4.4 Global Tysabri (natalizumab) Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Tysabri (natalizumab) Drug Sales by Manufacturers
3.1.1 Global Tysabri (natalizumab) Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Tysabri (natalizumab) Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tysabri (natalizumab) Drug in 2022
3.2 Global Tysabri (natalizumab) Drug Revenue by Manufacturers
3.2.1 Global Tysabri (natalizumab) Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Tysabri (natalizumab) Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Tysabri (natalizumab) Drug Revenue in 2022
3.3 Global Key Players of Tysabri (natalizumab) Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Tysabri (natalizumab) Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Tysabri (natalizumab) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tysabri (natalizumab) Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tysabri (natalizumab) Drug, Product Offered and Application
3.8 Global Key Manufacturers of Tysabri (natalizumab) Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tysabri (natalizumab) Drug Sales by Type
4.1.1 Global Tysabri (natalizumab) Drug Historical Sales by Type (2018-2024)
4.1.2 Global Tysabri (natalizumab) Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Tysabri (natalizumab) Drug Sales Market Share by Type (2018-2029)
4.2 Global Tysabri (natalizumab) Drug Revenue by Type
4.2.1 Global Tysabri (natalizumab) Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Tysabri (natalizumab) Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Tysabri (natalizumab) Drug Revenue Market Share by Type (2018-2029)
4.3 Global Tysabri (natalizumab) Drug Price by Type
4.3.1 Global Tysabri (natalizumab) Drug Price by Type (2018-2024)
4.3.2 Global Tysabri (natalizumab) Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Tysabri (natalizumab) Drug Sales by Application
5.1.1 Global Tysabri (natalizumab) Drug Historical Sales by Application (2018-2024)
5.1.2 Global Tysabri (natalizumab) Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Tysabri (natalizumab) Drug Sales Market Share by Application (2018-2029)
5.2 Global Tysabri (natalizumab) Drug Revenue by Application
5.2.1 Global Tysabri (natalizumab) Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Tysabri (natalizumab) Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Tysabri (natalizumab) Drug Revenue Market Share by Application (2018-2029)
5.3 Global Tysabri (natalizumab) Drug Price by Application
5.3.1 Global Tysabri (natalizumab) Drug Price by Application (2018-2024)
5.3.2 Global Tysabri (natalizumab) Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Tysabri (natalizumab) Drug Market Size by Type
6.1.1 US & Canada Tysabri (natalizumab) Drug Sales by Type (2018-2029)
6.1.2 US & Canada Tysabri (natalizumab) Drug Revenue by Type (2018-2029)
6.2 US & Canada Tysabri (natalizumab) Drug Market Size by Application
6.2.1 US & Canada Tysabri (natalizumab) Drug Sales by Application (2018-2029)
6.2.2 US & Canada Tysabri (natalizumab) Drug Revenue by Application (2018-2029)
6.3 US & Canada Tysabri (natalizumab) Drug Market Size by Country
6.3.1 US & Canada Tysabri (natalizumab) Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Tysabri (natalizumab) Drug Sales by Country (2018-2029)
6.3.3 US & Canada Tysabri (natalizumab) Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Tysabri (natalizumab) Drug Market Size by Type
7.1.1 Europe Tysabri (natalizumab) Drug Sales by Type (2018-2029)
7.1.2 Europe Tysabri (natalizumab) Drug Revenue by Type (2018-2029)
7.2 Europe Tysabri (natalizumab) Drug Market Size by Application
7.2.1 Europe Tysabri (natalizumab) Drug Sales by Application (2018-2029)
7.2.2 Europe Tysabri (natalizumab) Drug Revenue by Application (2018-2029)
7.3 Europe Tysabri (natalizumab) Drug Market Size by Country
7.3.1 Europe Tysabri (natalizumab) Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Tysabri (natalizumab) Drug Sales by Country (2018-2029)
7.3.3 Europe Tysabri (natalizumab) Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Tysabri (natalizumab) Drug Market Size
8.1.1 China Tysabri (natalizumab) Drug Sales (2018-2029)
8.1.2 China Tysabri (natalizumab) Drug Revenue (2018-2029)
8.2 China Tysabri (natalizumab) Drug Market Size by Application
8.2.1 China Tysabri (natalizumab) Drug Sales by Application (2018-2029)
8.2.2 China Tysabri (natalizumab) Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tysabri (natalizumab) Drug Market Size by Type
9.1.1 Asia Tysabri (natalizumab) Drug Sales by Type (2018-2029)
9.1.2 Asia Tysabri (natalizumab) Drug Revenue by Type (2018-2029)
9.2 Asia Tysabri (natalizumab) Drug Market Size by Application
9.2.1 Asia Tysabri (natalizumab) Drug Sales by Application (2018-2029)
9.2.2 Asia Tysabri (natalizumab) Drug Revenue by Application (2018-2029)
9.3 Asia Tysabri (natalizumab) Drug Sales by Region
9.3.1 Asia Tysabri (natalizumab) Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Tysabri (natalizumab) Drug Revenue by Region (2018-2029)
9.3.3 Asia Tysabri (natalizumab) Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Overview
11.1.3 Biogen Tysabri (natalizumab) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Biogen Tysabri (natalizumab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Tysabri (natalizumab) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Novartis Tysabri (natalizumab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tysabri (natalizumab) Drug Industry Chain Analysis
12.2 Tysabri (natalizumab) Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tysabri (natalizumab) Drug Production Mode & Process
12.4 Tysabri (natalizumab) Drug Sales and Marketing
12.4.1 Tysabri (natalizumab) Drug Sales Channels
12.4.2 Tysabri (natalizumab) Drug Distributors
12.5 Tysabri (natalizumab) Drug Customers
13 Market Dynamics
13.1 Tysabri (natalizumab) Drug Industry Trends
13.2 Tysabri (natalizumab) Drug Market Drivers
13.3 Tysabri (natalizumab) Drug Market Challenges
13.4 Tysabri (natalizumab) Drug Market Restraints
14 Key Findings in The Global Tysabri (natalizumab) Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tysabri (natalizumab) Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Multiple Sclerosis
Table 3. Major Manufacturers of Crohn's Disease
Table 4. Global Tysabri (natalizumab) Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Tysabri (natalizumab) Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Tysabri (natalizumab) Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Tysabri (natalizumab) Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Tysabri (natalizumab) Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Tysabri (natalizumab) Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Tysabri (natalizumab) Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Tysabri (natalizumab) Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Tysabri (natalizumab) Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Tysabri (natalizumab) Drug Sales Market Share by Region (2018-2024)
Table 14. Global Tysabri (natalizumab) Drug Sales Market Share by Region (2024-2029)
Table 15. Global Tysabri (natalizumab) Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Tysabri (natalizumab) Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Tysabri (natalizumab) Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Tysabri (natalizumab) Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Tysabri (natalizumab) Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Tysabri (natalizumab) Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Tysabri (natalizumab) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Tysabri (natalizumab) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tysabri (natalizumab) Drug as of 2022)
Table 23. Global Key Manufacturers of Tysabri (natalizumab) Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Tysabri (natalizumab) Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Tysabri (natalizumab) Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tysabri (natalizumab) Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Tysabri (natalizumab) Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Tysabri (natalizumab) Drug Sales Share by Type (2018-2024)
Table 30. Global Tysabri (natalizumab) Drug Sales Share by Type (2024-2029)
Table 31. Global Tysabri (natalizumab) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Tysabri (natalizumab) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Tysabri (natalizumab) Drug Revenue Share by Type (2018-2024)
Table 34. Global Tysabri (natalizumab) Drug Revenue Share by Type (2024-2029)
Table 35. Tysabri (natalizumab) Drug Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Tysabri (natalizumab) Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Tysabri (natalizumab) Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Tysabri (natalizumab) Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Tysabri (natalizumab) Drug Sales Share by Application (2018-2024)
Table 40. Global Tysabri (natalizumab) Drug Sales Share by Application (2024-2029)
Table 41. Global Tysabri (natalizumab) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Tysabri (natalizumab) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Tysabri (natalizumab) Drug Revenue Share by Application (2018-2024)
Table 44. Global Tysabri (natalizumab) Drug Revenue Share by Application (2024-2029)
Table 45. Tysabri (natalizumab) Drug Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Tysabri (natalizumab) Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Tysabri (natalizumab) Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Tysabri (natalizumab) Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Tysabri (natalizumab) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Tysabri (natalizumab) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Tysabri (natalizumab) Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Tysabri (natalizumab) Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Tysabri (natalizumab) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Tysabri (natalizumab) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Tysabri (natalizumab) Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Tysabri (natalizumab) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Tysabri (natalizumab) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Tysabri (natalizumab) Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Tysabri (natalizumab) Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Tysabri (natalizumab) Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Tysabri (natalizumab) Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Tysabri (natalizumab) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Tysabri (natalizumab) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Tysabri (natalizumab) Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Tysabri (natalizumab) Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Tysabri (natalizumab) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Tysabri (natalizumab) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Tysabri (natalizumab) Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Tysabri (natalizumab) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Tysabri (natalizumab) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Tysabri (natalizumab) Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Tysabri (natalizumab) Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Tysabri (natalizumab) Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Tysabri (natalizumab) Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Tysabri (natalizumab) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Tysabri (natalizumab) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Tysabri (natalizumab) Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Tysabri (natalizumab) Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Tysabri (natalizumab) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Tysabri (natalizumab) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Tysabri (natalizumab) Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Tysabri (natalizumab) Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Tysabri (natalizumab) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Tysabri (natalizumab) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Tysabri (natalizumab) Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Tysabri (natalizumab) Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Tysabri (natalizumab) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Tysabri (natalizumab) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Tysabri (natalizumab) Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Tysabri (natalizumab) Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Tysabri (natalizumab) Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Tysabri (natalizumab) Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Tysabri (natalizumab) Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales by Country (2024-2029) & (K Units)
Table 107. Biogen Company Information
Table 108. Biogen Description and Major Businesses
Table 109. Biogen Tysabri (natalizumab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Biogen Tysabri (natalizumab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Biogen Recent Developments
Table 112. Novartis Company Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Tysabri (natalizumab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Novartis Tysabri (natalizumab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Tysabri (natalizumab) Drug Distributors List
Table 120. Tysabri (natalizumab) Drug Customers List
Table 121. Tysabri (natalizumab) Drug Market Trends
Table 122. Tysabri (natalizumab) Drug Market Drivers
Table 123. Tysabri (natalizumab) Drug Market Challenges
Table 124. Tysabri (natalizumab) Drug Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Tysabri (natalizumab) Drug Product Picture
Figure 2. Global Tysabri (natalizumab) Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Tysabri (natalizumab) Drug Market Share by Type in 2022 & 2029
Figure 4. Multiple Sclerosis Product Picture
Figure 5. Crohn's Disease Product Picture
Figure 6. Global Tysabri (natalizumab) Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Tysabri (natalizumab) Drug Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drugs Stores
Figure 10. Tysabri (natalizumab) Drug Report Years Considered
Figure 11. Global Tysabri (natalizumab) Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Tysabri (natalizumab) Drug Revenue 2018-2029 (US$ Million)
Figure 13. Global Tysabri (natalizumab) Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Tysabri (natalizumab) Drug Revenue Market Share by Region (2018-2029)
Figure 15. Global Tysabri (natalizumab) Drug Sales 2018-2029 ((K Units)
Figure 16. Global Tysabri (natalizumab) Drug Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Tysabri (natalizumab) Drug Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Tysabri (natalizumab) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Tysabri (natalizumab) Drug Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Tysabri (natalizumab) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Tysabri (natalizumab) Drug Sales YoY (2018-2029) & (K Units)
Figure 22. China Tysabri (natalizumab) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Tysabri (natalizumab) Drug Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Tysabri (natalizumab) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Tysabri (natalizumab) Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Tysabri (natalizumab) Drug in the World: Market Share by Tysabri (natalizumab) Drug Revenue in 2022
Figure 29. Global Tysabri (natalizumab) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Tysabri (natalizumab) Drug Sales Market Share by Type (2018-2029)
Figure 31. Global Tysabri (natalizumab) Drug Revenue Market Share by Type (2018-2029)
Figure 32. Global Tysabri (natalizumab) Drug Sales Market Share by Application (2018-2029)
Figure 33. Global Tysabri (natalizumab) Drug Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Tysabri (natalizumab) Drug Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Tysabri (natalizumab) Drug Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Tysabri (natalizumab) Drug Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Tysabri (natalizumab) Drug Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Tysabri (natalizumab) Drug Revenue Share by Country (2018-2029)
Figure 39. US & Canada Tysabri (natalizumab) Drug Sales Share by Country (2018-2029)
Figure 40. U.S. Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Tysabri (natalizumab) Drug Sales Market Share by Type (2018-2029)
Figure 43. Europe Tysabri (natalizumab) Drug Revenue Market Share by Type (2018-2029)
Figure 44. Europe Tysabri (natalizumab) Drug Sales Market Share by Application (2018-2029)
Figure 45. Europe Tysabri (natalizumab) Drug Revenue Market Share by Application (2018-2029)
Figure 46. Europe Tysabri (natalizumab) Drug Revenue Share by Country (2018-2029)
Figure 47. Europe Tysabri (natalizumab) Drug Sales Share by Country (2018-2029)
Figure 48. Germany Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 49. France Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 50. UK Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 53. China Tysabri (natalizumab) Drug Sales Market Share by Type (2018-2029)
Figure 54. China Tysabri (natalizumab) Drug Revenue Market Share by Type (2018-2029)
Figure 55. China Tysabri (natalizumab) Drug Sales Market Share by Application (2018-2029)
Figure 56. China Tysabri (natalizumab) Drug Revenue Market Share by Application (2018-2029)
Figure 57. Asia Tysabri (natalizumab) Drug Sales Market Share by Type (2018-2029)
Figure 58. Asia Tysabri (natalizumab) Drug Revenue Market Share by Type (2018-2029)
Figure 59. Asia Tysabri (natalizumab) Drug Sales Market Share by Application (2018-2029)
Figure 60. Asia Tysabri (natalizumab) Drug Revenue Market Share by Application (2018-2029)
Figure 61. Asia Tysabri (natalizumab) Drug Revenue Share by Region (2018-2029)
Figure 62. Asia Tysabri (natalizumab) Drug Sales Share by Region (2018-2029)
Figure 63. Japan Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 67. India Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Tysabri (natalizumab) Drug Sales Share by Country (2018-2029)
Figure 74. Brazil Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Tysabri (natalizumab) Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Tysabri (natalizumab) Drug Value Chain
Figure 80. Tysabri (natalizumab) Drug Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed